HIV

In a new study published in the Journal of Managed Care Pharmacy, investigators interviewed patients and pharmacists about the costs and benefits of obtaining antiretroviral therapies from a community pharmacy.

The FDA approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection.

Community pharmacists interviewed for a recently published study were eager to play a role in counseling patients who use over-the-counter HIV tests.

Community pharmacists interviewed for a recently published study were eager to play a role in counseling patients who use over-the-counter HIV tests.

A new study released by the Tufts Center for the Study of Drug Development reports that annual drug approvals for neglected diseases have nearly doubled since 2000, and patient access to these therapies has improved markedly.

Armada Health Care announced today that the AIDS Healthcare Foundation (AHF) has chosen Armada to be its primary purchasing partner.

A study assessing HIV treatment interruption in 14 French subjects suggests that early initiation of antiretroviral therapy may be associated with sustained virological remission.

A child born to a mother infected with HIV and aggressively treated with antiretroviral therapy starting shortly after birth appears to have been cured of HIV.

A child born to a mother infected with HIV and aggressively treated with antiretroviral therapy starting shortly after birth appears to have been cured of HIV.

Health insurer Anthem pulled the plug on a policy in California that would require patients to get their specialty drugs through the mail.

Sterility is not maintained by putting a new needle on a used pen device.

Pharmacoenhancers can help minimize costs and maximize effectiveness.

The class action lawsuit against Anthem Blue Cross alleges their policy mandating that patients use a mail-order specialty pharmacy discriminates against HIV patients.

AIDS Healthcare Foundation (AHF), announced that following its August 2012 acquisition of MOMS Pharmacy, a specialty pharmacy focused exclusively on providing medications and support services to people living with HIV/AIDS, it is fully incorporating and rebranding the chain into its own AHF Pharmacy brand.

FHI 360 President Emeritus Ward Cates discusses the HIV treatment cascade. This model aims to bring us closer to the end of AIDS by addressing the gaps in the HIV diagnosis and treatment system currently in place.

Arun K. Ghosh. professor of organic and medicinal chemistry at Purdue University, talks with Hiroaki Mitsuya, Head of Experimental Retrovirology Section at the National Cancer Institute, about HIV drug development.

2 major HIV provider groups recently sent pharmaceutical companies and manufacturers a statement urging them to make their antiretrovirals more accessible to patients.

The FDA approved Gilead Sciences, Inc.'s Truvada (emtricitabine 200 mg/tenofovir disproxil fumarate 300 mg) in combination with safer sex practices for pre-exposure prophylaxis.

A study found that melanoma is more common in immunosuppressed patients, including patients with a prior solid organ transplant, patients with lymphoma, and patients with HIV/AIDS.

Truvada (emtricitabine/tenofovir disoproxil fumarate) was approved for prophylaxis to reduce the risk of HIV-1 infection in adults.

There have been significant increases in the cost of antiretroviral therapies (ART) for individual therapies and in the cost of therapy initiation over the past several years.

Making birth control pills available OTC would increase women's access to them and reduce the rate of unintended pregnancy, but issues such as reimbursement for pharmacist services still need to be worked out, the group argues.

New recommendations from the task force say that all Americans aged 15 to 64 years should get an HIV test regardless of their risk for contracting the virus.

In a session at the 2012 Academy of Managed Care Pharmacy Educational Conference, Aimee Tharaldson, PharmD, identified the top specialty drugs in the pipeline and highlighted the most recent therapeutic trends within each medication class.

The latest advances in HIV treatment and care include new drug therapies, a new at-home test, and updates guidelines for antiretroviral therapy for pregnant women.